binimetinib

OncoDaily

News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary

Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me

May, 2025

binimetinib

Apr 23, 2025, 10:15 | Drugs

Binimetinib (Mektovi): What patients need to know?

Binimetinib, sold under the brand name Mektovi, is an FDA-approved oral medication used to treat…

Apr 22, 2025, 15:25 | Drugs

Binimetinib (Mektovi): Uses in Cancer, Side effects, Dosage, Expectations, and more

Binimetinib is an oral targeted cancer therapy that belongs to a class of drugs known…

Oct 6, 2024, 14:01 | Insight

MD Anderson Research Highlights

The University of Texas MD Anderson Cancer Center’s Research Highlights showcases the latest breakthroughs in…

Jun 1, 2024, 12:11 | Societies

Carlos Torrado: Excited to present our poster at ASCO24

Carlos Torrado, Clinical Fellow at MD Anderson Cancer Center, recently shared a post by NCI…

Apr 17, 2024, 13:11 | Insight

New Paper Alert! Exploring Treatment Strategies After Progression to BRAF V600E-Targeted Therapy in Metastatic Colorectal Cancer: A Real-World Analysis

New Paper Alert: Exploring Treatment Strategies After Progression to BRAF V600E-Targeted Therapy in Metastatic Colorectal…

Oct 13, 2023, 17:10 | Drugs

Rami Manochakian: FDA Oncology approves the combination of Encorafenib and Binimetinib for Patients with metastatic Non-Small cell Lung Cancer with a BRAF V600E mutation.

Jul 10, 2023, 19:11 | Drugs

Today in Mexico City we launched the combination of encorafenib and binimetinib approved for adult patients with inoperable or metastatic melanoma positive at BRAF V600 mutation - Paolo A. Ascierto

All: 7 Posts: 1 - 100

'

Oncologist Near Me – Yan Leyfman: A Voice for Innovation, Mentorship, and Impact in Oncology

'

Richard Goldberg: Agenus Anticipates Interacting with FDA with New Data Coming at ESMO-GI 2025

'

USA vs Europe: Who Does Cancer Screening Better?

'

A Call for Peace from the Frontlines of Pediatric Oncology by the POEM Group

'

Servier Acquires Precision Therapy for Acute Leukemias from BioNova Pharmaceuticals

Special Coverage

Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
ESMO 2024 Congress
September 13-17, 2024
ASCO Annual Meeting
May 30 - June 4, 2024
Yvonne Award 2024
May 31, 2024
OncoThon 2024, Online
Feb. 15, 2024
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023